Cargando…

A Case of Severe, Nilotinib-Induced Liver Injury

Idiosyncratic hepatotoxicity is a leading reason for the discontinuation or dose modification of Food and Drug Administration (FDA)-approved medications in the United States. We report the case of a 53-year-old woman with chronic myeloid leukemia who developed acute cholestatic hepatitis in response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Belopolsky, Yuliya, Grinblatt, David L., Dunnenberger, Henry M., Sabatini, Linda M., Joseph, Nora E., Fimmel, Claus J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657995/ https://www.ncbi.nlm.nih.gov/pubmed/31616712 http://dx.doi.org/10.14309/crj.0000000000000003

Ejemplares similares

Ketogenic, Hypocaloric Diet Improves Nonalcoholic Steatohepatitis
por: Belopolsky, Yuliya, et al.
Publicado: (2020)

Nilotinib-induced liver injury: A case report
por: Tan, Youwen, et al.
Publicado: (2020)

Effect of a Best Practice Alert on Birth-Cohort Screening for Hepatitis C Virus
por: Khan, Mohammad Qasim, et al.
Publicado: (2021)

Nilotinib-induced Perforating Folliculitis: Two Cases
por: Saraswat, Neerja, et al.
Publicado: (2018)

Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic Option
por: Yang, Hyun, et al.
Publicado: (2020)

Nilotinib-Associated Destructive Thyroiditis
por: Bakerywala, Suhalia, et al.
Publicado: (2015)

Nilotinib-Induced Keratosis Pilaris
por: Leong, Wai Mun Sean, et al.
Publicado: (2016)

Symptomatic Acute Pancreatitis Induced by Nilotinib: A Report of Two Cases
por: Yamada, Toshiki, et al.
Publicado: (2016)

Nilotinib: QTc prolongation: 2 case reports
Publicado: (2021)

Nilotinib-Induced Acute Pancreatitis in a Patient with Chronic Myeloid Leukemia
por: Patel, Vihang, et al.
Publicado: (2017)

Relapse of HCV Genotype 1b Infection After Sofosbuvir/Ledipasvir Treatment Presenting as De Novo Cryoglobulinemic Vasculitis
por: Khan, Mohammad Qasim, et al.
Publicado: (2017)

Hepatitis B Virus Reactivation under Treatment with Nilotinib
por: Temel, Tuncer, et al.
Publicado: (2015)

Nilotinib Induced Recurrent Gastric Polyps: Case Report and Review of Literature
por: Kassem, Nancy, et al.
Publicado: (2017)

Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib
por: Stacchiotti, Silvia, et al.
Publicado: (2013)

Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
por: Na, Yoo Jin, et al.
Publicado: (2021)

Water-jet vs traditional triangular tip knife in peroral endoscopic myotomy for esophageal dysmotility: A systemic review and meta-analysis
por: Belopolsky, Yuliya, et al.
Publicado: (2022)

Pleural Effusion: A Rare Side Effect of Nilotinib—A Case Report
por: Üsküdar Teke, Hava, et al.
Publicado: (2014)

Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia
por: Inoue, Hiroyasu, et al.
Publicado: (2020)

Nilotinib-Induced Dystonia and Cognitive Deficits in a Neurologically Normal Patient with Chronic Myeloid Leukemia
por: Chan, Justine, et al.
Publicado: (2019)

Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study
por: Hochhaus, Andreas, et al.
Publicado: (2015)

Nilotinib-induced generalized keratosis pilaris: Report of a rare case
por: Kowe, Priyanka Arun, et al.
Publicado: (2021)

A case report of nilotinib-induced irreversible interstitial lung disease
por: Cho, Jun Yeun, et al.
Publicado: (2022)

Ibrutinib‐induced severe liver injury
por: Nandikolla, Amara G., et al.
Publicado: (2017)

Antifibrotic Effect of Combination of Nilotinib and Stem Cell-Conditioned Media on CCl(4)-Induced Liver Fibrosis
por: Shiha, Gamal, et al.
Publicado: (2020)

Liver transplantation for azithromycin-induced severe liver injury
por: Park, Hyun Joon, et al.
Publicado: (2020)

Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib
por: Maruta, Shunsuke, et al.
Publicado: (2021)

Évolution de leucémies myéloïdes chroniques sous nilotinib après échec a l'imatinib
por: Sawadogo, Salifo, et al.
Publicado: (2014)

Response and Adherence to Nilotinib in Daily practice (RAND study): an in-depth observational study of chronic myeloid leukemia patients treated with nilotinib
por: Boons, Christel C. L. M., et al.
Publicado: (2020)

Safe discontinuation of nilotinib in a patient with chronic myeloid leukemia: a case report
por: Caocci, Giovanni, et al.
Publicado: (2014)

Nilotinib based pharmacophore models for BCRABL
por: Sabitha, Kesavan
Publicado: (2012)

Nilotinib – Differentiating the Hope from the Hype
por: Wyse, Richard K., et al.
Publicado: (2016)

Development of Myasthenia Gravis in a Patient with Chronic Myeloid Leukemia during Treatment with Nilotinib
por: Sanford, David, et al.
Publicado: (2014)

S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCTION AND NILOTINIB OR PEG-INTERFERON ΑLPHA MAINTENANCE THERAPY FOR NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS. THE TIGER TRIAL.
por: Hochhaus, Andreas, et al.
Publicado: (2023)

Nilotinib-Induced Elephantine Psoriasis In a Patient With Chronic Myeloid Leukemia: A Rare Case Report and Literature Review
por: Sadatmadani, Seyedeh Fatemeh, et al.
Publicado: (2022)

Progressive changes in platelet counts and Fib-4 scores precede the diagnosis of advanced fibrosis in NASH patients
por: Zijlstra, Michael K, et al.
Publicado: (2023)

A Rare Case of Hypereosinophilic Syndrome-Induced Shower Thrombus Responsive to Nilotinib
por: Lambird, Elise, et al.
Publicado: (2020)

Aortic Stenosis and the Tyrosine Kinase Inhibitor Nilotinib in Chronic Myeloid Leukemia
por: Carracedo, Miguel, et al.
Publicado: (2020)

Extensive intracranial arterial stenoses in conjunction with the use of tyrosine kinase inhibitor Nilotinib
por: Alshiekh‐Nasany, Ruham, et al.
Publicado: (2016)

Lichen planopilaris-like eruption during treatment with tyrosine kinase inhibitor nilotinib
por: Leitão, Juliana Ribeiro, et al.
Publicado: (2016)

Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
por: Al-Dubai, Husam N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m28qe80alise5tc6a4l4hl77de